MMP 9 Gene Promoter Polymorphism in Gastric Cancer

• Published in: Indian journal of clinical biochemistry Vol. 27; no. 3; pp. 259 - 264
• Main Authors: Krishnaveni, D., Bhayal, Amar Chand, Sri Manjari, K., Vidyasagar, A., Uma Devi, M., Ramanna, M., Jyothy, A., Nallari, Pratibha, Venkateshwari, A.
• Format: Journal Article
• Language: English
• Published: India Springer-Verlag 01.07.2012; Springer; Springer Nature B.V
• Subjects: Biochemistry; Biomedical and Life Sciences; Cancer; Chemistry/Food Science; Development and progression; Epidemiology; Gastrointestinal diseases; Genes; Genetic aspects; Life Sciences; Metastasis; Microbiology; Original; Original Article; Pathology; Polymorphism; Single nucleotide polymorphisms; Stomach cancer; Matrix metalloproteinase-9; Metastasis; Gastric cancer; Polymorphism
• ISSN: 0970-1915; 0974-0422
• DOI: 10.1007/s12291-012-0210-2

Matrix metalloproteinase-9 (gelatinase B) plays a key role in cancer invasion and metastasis by degrading the extracellular matrix and basement membrane barriers. A cytosine (C) > thymidine (T) single nucleotide polymorphism (SNP) at position −1562 in the MMP-9 promoter is reported to influence the expression of the gene. Genotyping of MMP-9 −1562 C→T promoter polymorphism in 140 gastric cancer patients and 132 healthy control subjects was carried out in order to evaluate its association with progression and development of gastric cancer. The SNP was genotyped by tetra-primer amplification refractory mutation system-polymerase chain reaction followed by agarose gel electrophoresis. Statistical methods were adopted to test for the significance of the results. Risk factor profile of the patients revealed age above 50 years, smoking, alcoholism as the factors associated with the disease. The distribution of genotype frequencies in gastric cancer patients were 28.7 % of CC, 45.5 % of CT and 25.7 % of TT, whereas in control subjects 31.8 % of CC, 53.03 % of CT and 15.15 % of TT, respectively. The allelic frequencies were 51.51 % of C and 48.48 % of T in patient group and 58.33 % of C and 41.66 % of T in controls respectively. The present study shows the possible association of epidemiological risk factors with gastric cancer. There is an increased frequency of T allele in the disease compared to control subjects. However, there is no association of the MMP-9 −1562 C→T promoter polymorphism in the development of gastric cancer.